Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
eye diseases
Pharma
GLP-1 use in diabetes linked to possible eye disease risk: study
The study pointed to a twofold higher risk of developing neovascular age-related macular degeneration for diabetes patients on GLP-1 meds.
Zoey Becker
Jun 6, 2025 7:25am
Novartis expands collaboration with Shanghai Pharma in China
May 27, 2025 10:08am
Apellis' Syfovre faces tough road ahead in GA market: analyst
May 14, 2025 11:10am
Neurotech nabs first nod for eye disease cell therapy implant
Mar 10, 2025 9:50am
Astellas, Mitsubishi Tanabe, Leqembi—Fierce Pharma Asia
Feb 14, 2025 9:51am
Tenpoint preps FDA filing after scoring in presbyopia study
Jan 9, 2025 3:39pm
